Halozyme Therapeutics Basic EPS 2010-2024 | HALO

Halozyme Therapeutics basic eps for the twelve months ending June 30, 2024 was $2.61, a 50% increase year-over-year.

  • Halozyme Therapeutics annual basic eps for 2023 was $0.002B, a 43.92% increase from 2022.
  • Halozyme Therapeutics annual basic eps for 2022 was $0.001B, a 48.25% decline from 2021.
  • Halozyme Therapeutics annual basic eps for 2021 was $0.003B, a 201.05% increase from 2020.

Halozyme Therapeutics Basic EPS 2010-2024 | HALO

  • Halozyme Therapeutics annual basic eps for 2023 was $0.002B, a 43.92% increase from 2022.
  • Halozyme Therapeutics annual basic eps for 2022 was $0.001B, a 48.25% decline from 2021.
  • Halozyme Therapeutics annual basic eps for 2021 was $0.003B, a 201.05% increase from 2020.